EMEA (Europe, Middle East and Africa) ADHD Drugs Market Report 2017

December 2017 | 105 pages | ID: ED6E6E199ECEN
QYResearch

Abstracts

In this report, the EMEA ADHD Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of ADHD Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA ADHD Drugs market competition by top manufacturers/players, with ADHD Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Janssen Pharmaceuticals, Inc.
• Shire
• Perdue Pharma
• Glaxosmith Kline
• Novartis
• Celltech Group
• Johnson & Johnson

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Stimulants (Amphetamines, Methylphenidate)
• Non-Stimulants
• Antidepressants
• Blood Pressure Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adults
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) ADHD Drugs Market Report 2017

1 ADHD DRUGS OVERVIEW

1.1 Product Overview and Scope of ADHD Drugs
1.2 Classification of ADHD Drugs
  1.2.1 EMEA ADHD Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA ADHD Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Stimulants (Amphetamines, Methylphenidate)
  1.2.4 Non-Stimulants
  1.2.5 Antidepressants
  1.2.6 Blood Pressure Medicines
1.3 EMEA ADHD Drugs Market by Application/End Users
  1.3.1 EMEA ADHD Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Adults
  1.3.3 Children
1.4 EMEA ADHD Drugs Market by Region
  1.4.1 EMEA ADHD Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of ADHD Drugs (2012-2022)
  1.5.1 EMEA ADHD Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA ADHD Drugs Revenue and Growth Rate (2012-2022)

2 EMEA ADHD DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA ADHD Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA ADHD Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA ADHD Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA ADHD Drugs Sale Price by Players (2012-2017)
2.2 EMEA ADHD Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA ADHD Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA ADHD Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA ADHD Drugs Sale Price by Type (2012-2017)
2.3 EMEA ADHD Drugs (Volume) by Application
2.4 EMEA ADHD Drugs (Volume and Value) by Region
  2.4.1 EMEA ADHD Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA ADHD Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA ADHD Drugs Sales Price by Region (2012-2017)

3 EUROPE ADHD DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe ADHD Drugs Sales and Value (2012-2017)
  3.1.1 Europe ADHD Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe ADHD Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe ADHD Drugs Sales and Market Share by Type
3.3 Europe ADHD Drugs Sales and Market Share by Application
3.4 Europe ADHD Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe ADHD Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe ADHD Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany ADHD Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France ADHD Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK ADHD Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia ADHD Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy ADHD Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux ADHD Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ADHD DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East ADHD Drugs Sales and Value (2012-2017)
  4.1.1 Middle East ADHD Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East ADHD Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East ADHD Drugs Sales and Market Share by Type
4.3 Middle East ADHD Drugs Sales and Market Share by Application
4.4 Middle East ADHD Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East ADHD Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East ADHD Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia ADHD Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel ADHD Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE ADHD Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran ADHD Drugs Sales and Growth Rate (2012-2017)

5 AFRICA ADHD DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa ADHD Drugs Sales and Value (2012-2017)
  5.1.1 Africa ADHD Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa ADHD Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa ADHD Drugs Sales and Market Share by Type
5.3 Africa ADHD Drugs Sales and Market Share by Application
5.4 Africa ADHD Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa ADHD Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa ADHD Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa ADHD Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria ADHD Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt ADHD Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria ADHD Drugs Sales and Growth Rate (2012-2017)

6 EMEA ADHD DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 ADHD Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Janssen Pharmaceuticals, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 ADHD Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shire
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 ADHD Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Perdue Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 ADHD Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Glaxosmith Kline
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 ADHD Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 ADHD Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Celltech Group
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 ADHD Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 ADHD Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ADHD DRUGS MANUFACTURING COST ANALYSIS

7.1 ADHD Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of ADHD Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 ADHD Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ADHD DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA ADHD Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA ADHD Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA ADHD Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA ADHD Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA ADHD Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe ADHD Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt ADHD Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa ADHD Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA ADHD Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA ADHD Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of ADHD Drugs
Figure EMEA ADHD Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA ADHD Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Stimulants (Amphetamines, Methylphenidate) Product Picture
Figure Non-Stimulants Product Picture
Figure Antidepressants Product Picture
Figure Blood Pressure Medicines Product Picture
Figure EMEA ADHD Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of ADHD Drugs by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure EMEA ADHD Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe ADHD Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East ADHD Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa ADHD Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA ADHD Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA ADHD Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA ADHD Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA ADHD Drugs Sales Share by Players (2012-2017)
Figure 2016 ADHD Drugs Sales Share by Players
Figure 2017 ADHD Drugs Sales Share by Players
Figure EMEA ADHD Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA ADHD Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA ADHD Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA ADHD Drugs Revenue Share by Players
Table 2017 EMEA ADHD Drugs Revenue Share by Players
Table EMEA ADHD Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA ADHD Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA ADHD Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of ADHD Drugs by Type (2012-2017)
Figure EMEA ADHD Drugs Sales Market Share by Type (2012-2017)
Table EMEA ADHD Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA ADHD Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of ADHD Drugs by Type in 2016
Table EMEA ADHD Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA ADHD Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA ADHD Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of ADHD Drugs by Application (2012-2017)
Figure EMEA ADHD Drugs Sales Market Share by Application in 2016
Table EMEA ADHD Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA ADHD Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of ADHD Drugs by Region (2012-2017)
Figure EMEA ADHD Drugs Sales Market Share in 2016
Table EMEA ADHD Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA ADHD Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of ADHD Drugs by Region (2012-2017)
Figure EMEA ADHD Drugs Revenue Market Share Regions in 2016
Table EMEA ADHD Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe ADHD Drugs Revenue and Growth Rate (2012-2017)
Table Europe ADHD Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe ADHD Drugs Market Share by Type (2012-2017)
Figure Europe ADHD Drugs Market Share by Type in 2016
Table Europe ADHD Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe ADHD Drugs Market Share by Application (2012-2017)
Figure Europe ADHD Drugs Market Share by Application in 2016
Table Europe ADHD Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe ADHD Drugs Sales Market Share by Countries (2012-2017)
Figure Europe ADHD Drugs Sales Market Share by Countries (2012-2017)
Figure Europe ADHD Drugs Sales Market Share by Countries in 2016
Table Europe ADHD Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe ADHD Drugs Revenue Market Share by Countries in 2016
Figure Germany ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East ADHD Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East ADHD Drugs Market Share by Type (2012-2017)
Figure Middle East ADHD Drugs Market Share by Type (2012-2017)
Table Middle East ADHD Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East ADHD Drugs Market Share by Applications (2012-2017)
Figure Middle East ADHD Drugs Sales Market Share by Application in 2016
Table Middle East ADHD Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East ADHD Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East ADHD Drugs Sales Volume Market Share by Countries in 2016
Table Middle East ADHD Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East ADHD Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa ADHD Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa ADHD Drugs Sales Market Share by Type (2012-2017)
Figure Africa ADHD Drugs Sales Market Share by Type (2012-2017)
Figure Africa ADHD Drugs Sales Market Share by Type in 2016
Table Africa ADHD Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa ADHD Drugs Sales Market Share by Application (2012-2017)
Figure Africa ADHD Drugs Sales Market Share by Application (2012-2017)
Table Africa ADHD Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa ADHD Drugs Sales Market Share by Countries (2012-2017)
Figure Africa ADHD Drugs Sales Market Share by Countries (2012-2017)
Figure Africa ADHD Drugs Sales Market Share by Countries in 2016
Table Africa ADHD Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa ADHD Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa ADHD Drugs Revenue Market Share by Countries in 2016
Figure South Africa ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Eli Lilly ADHD Drugs Basic Information List
Table Eli Lilly ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Janssen Pharmaceuticals, Inc. ADHD Drugs Basic Information List
Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Shire ADHD Drugs Basic Information List
Table Shire ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shire ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Shire ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Perdue Pharma ADHD Drugs Basic Information List
Table Perdue Pharma ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perdue Pharma ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Perdue Pharma ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Perdue Pharma ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Glaxosmith Kline ADHD Drugs Basic Information List
Table Glaxosmith Kline ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis ADHD Drugs Basic Information List
Table Novartis ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Celltech Group ADHD Drugs Basic Information List
Table Celltech Group ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltech Group ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celltech Group ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Celltech Group ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson ADHD Drugs Basic Information List
Table Johnson & Johnson ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson ADHD Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson ADHD Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ADHD Drugs
Figure Manufacturing Process Analysis of ADHD Drugs
Figure ADHD Drugs Industrial Chain Analysis
Table Raw Materials Sources of ADHD Drugs Major Manufacturers in 2016
Table Major Buyers of ADHD Drugs
Table Distributors/Traders List
Figure EMEA ADHD Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA ADHD Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA ADHD Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA ADHD Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA ADHD Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA ADHD Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA ADHD Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe ADHD Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe ADHD Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe ADHD Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe ADHD Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East ADHD Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East ADHD Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East ADHD Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East ADHD Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa ADHD Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa ADHD Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa ADHD Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa ADHD Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA ADHD Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA ADHD Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA ADHD Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA ADHD Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources